231 related articles for article (PubMed ID: 32176314)
1. Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy.
Pawlowski P; Poplawska I; Mysliwiec J; Dik WA; Eckstein A; Berchner-Pfannschmidt U; Milewski R; Lawicki S; Dzieciol-Anikiej Z; Rejdak R; Reszec J
Folia Histochem Cytobiol; 2020; 58(1):37-45. PubMed ID: 32176314
[TBL] [Abstract][Full Text] [Related]
2. Markers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implications.
Pawlowski P; Reszec J; Eckstein A; Johnson K; Grzybowski A; Chyczewski L; Mysliwiec J
Mediators Inflamm; 2014; 2014():412158. PubMed ID: 25309050
[TBL] [Abstract][Full Text] [Related]
3. Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
Lee CE; Choi SH; Yoon JS
Korean J Ophthalmol; 2020 Jun; 34(3):192-202. PubMed ID: 32495527
[TBL] [Abstract][Full Text] [Related]
4. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract][Full Text] [Related]
5. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Dik WA; Virakul S; van Steensel L
Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy.
Shih SR; Liao SL; Shih CW; Wei YH; Lu TX; Chou CH; Yen EY; Chang YC; Lin CC; Chi YC; Yang WS; Tsai FC
Ocul Immunol Inflamm; 2021 Jan; 29(1):193-202. PubMed ID: 31657648
[No Abstract] [Full Text] [Related]
8. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
[TBL] [Abstract][Full Text] [Related]
9. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.
Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
PLoS One; 2019; 14(8):e0221077. PubMed ID: 31415657
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.
Hai YP; Lee ACH; Frommer L; Diana T; Kahaly GJ
J Endocrinol Invest; 2020 Feb; 43(2):123-137. PubMed ID: 31538314
[TBL] [Abstract][Full Text] [Related]
13. Genetic Profiling of Orbital Fibroblasts from Patients with Graves' Orbitopathy.
Rotondo Dottore G; Bucci I; Lanzolla G; Dallan I; Sframeli A; Torregrossa L; Casini G; Basolo F; Figus M; Nardi M; Marcocci C; Marinò M
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2176-e2190. PubMed ID: 33484567
[TBL] [Abstract][Full Text] [Related]
14. Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts.
Galgoczi E; Jeney F; Gazdag A; Erdei A; Katko M; Nagy DM; Ujhelyi B; Steiber Z; Gyory F; Berta E; Nagy EV
J Endocrinol; 2016 May; 229(2):187-96. PubMed ID: 26979769
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
Moshkelgosha S; So PW; Deasy N; Diaz-Cano S; Banga JP
Endocrinology; 2013 Sep; 154(9):3008-15. PubMed ID: 23900776
[TBL] [Abstract][Full Text] [Related]
16. Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells.
Brandau S; Bruderek K; Hestermann K; Görtz GE; Horstmann M; Mattheis S; Lang S; Eckstein A; Berchner-Pfannschmidt U
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6549-57. PubMed ID: 26457540
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cell-Like Properties of Orbital Fibroblasts in Graves' Orbitopathy.
Kozdon K; Fitchett C; Rose GE; Ezra DG; Bailly M
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5743-50. PubMed ID: 26325413
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.
Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA
Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982
[TBL] [Abstract][Full Text] [Related]
19. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
20. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
Zhang M; Ding X; Wu LP; He MQ; Chen ZY; Shi BY; Wang Y
Thyroid; 2021 Apr; 31(4):638-648. PubMed ID: 33076782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
